Past decade8 Mar 2019 21:56
You have to bear in mind that some pharmas will have got FDA approval but the drug is not life changing or is in a very competitive market area.
Iclaprim is a big leap in AB that could have a massive market full of old ABs that have become ineffective. Motif have a no el AB that could change peoples lives.
Hence it is unique in comparison with other small pharma success stories.